520 related articles for article (PubMed ID: 23686496)
21. Annexin 1 exerts anti-nociceptive effects after peripheral inflammatory pain through formyl-peptide-receptor-like 1 in rat dorsal root ganglion.
Pei L; Zhang J; Zhao F; Su T; Wei H; Tian J; Li M; Shi J
Br J Anaesth; 2011 Dec; 107(6):948-58. PubMed ID: 21990306
[TBL] [Abstract][Full Text] [Related]
22. Opposing regulation of neutrophil apoptosis through the formyl peptide receptor-like 1/lipoxin A4 receptor: implications for resolution of inflammation.
El Kebir D; József L; Filep JG
J Leukoc Biol; 2008 Sep; 84(3):600-6. PubMed ID: 18495783
[TBL] [Abstract][Full Text] [Related]
23. Activation of annexin A1 signalling in renal fibroblasts exerts antifibrotic effects.
Neymeyer H; Labes R; Reverte V; Saez F; Stroh T; Dathe C; Hohberger S; Zeisberg M; Müller GA; Salazar J; Bachmann S; Paliege A
Acta Physiol (Oxf); 2015 Nov; 215(3):144-58. PubMed ID: 26332853
[TBL] [Abstract][Full Text] [Related]
24. Design and characterization of a cleavage-resistant Annexin A1 mutant to control inflammation in the microvasculature.
Pederzoli-Ribeil M; Maione F; Cooper D; Al-Kashi A; Dalli J; Perretti M; D'Acquisto F
Blood; 2010 Nov; 116(20):4288-96. PubMed ID: 20705760
[TBL] [Abstract][Full Text] [Related]
25. Alterations in the profile of blood neutrophil membrane receptors caused by in vivo adrenocorticotrophic hormone actions.
Machado ID; Santin JR; Drewes CC; Gil CD; Oliani SM; Perretti M; Farsky SH
Am J Physiol Endocrinol Metab; 2014 Nov; 307(9):E754-63. PubMed ID: 25184992
[TBL] [Abstract][Full Text] [Related]
26. Targeting the AnxA1/Fpr2/ALX pathway regulates neutrophil function, promoting thromboinflammation resolution in sickle cell disease.
Ansari J; Senchenkova EY; Vital SA; Al-Yafeai Z; Kaur G; Sparkenbaugh EM; Orr AW; Pawlinski R; Hebbel RP; Granger DN; Kubes P; Gavins FNE
Blood; 2021 Mar; 137(11):1538-1549. PubMed ID: 33512489
[TBL] [Abstract][Full Text] [Related]
27. Targeting formyl peptide receptor 2 reduces leukocyte-endothelial interactions in a murine model of stroke.
Smith HK; Gil CD; Oliani SM; Gavins FN
FASEB J; 2015 May; 29(5):2161-71. PubMed ID: 25690650
[TBL] [Abstract][Full Text] [Related]
28. Ligand-specific conformational change of the G-protein-coupled receptor ALX/FPR2 determines proresolving functional responses.
Cooray SN; Gobbetti T; Montero-Melendez T; McArthur S; Thompson D; Clark AJ; Flower RJ; Perretti M
Proc Natl Acad Sci U S A; 2013 Nov; 110(45):18232-7. PubMed ID: 24108355
[TBL] [Abstract][Full Text] [Related]
29. Stimulus-dependent specificity for annexin 1 inhibition of the inflammatory nociceptive response: the involvement of the receptor for formylated peptides.
Pieretti S; Di Giannuario A; De Felice M; Perretti M; Cirino G
Pain; 2004 May; 109(1-2):52-63. PubMed ID: 15082126
[TBL] [Abstract][Full Text] [Related]
30. 15-Epi-LXA
Sekheri M; El Kebir D; Edner N; Filep JG
Proc Natl Acad Sci U S A; 2020 Apr; 117(14):7971-7980. PubMed ID: 32205444
[TBL] [Abstract][Full Text] [Related]
31. Regulation of lung fibroblast activation by annexin A1.
Jia Y; Morand EF; Song W; Cheng Q; Stewart A; Yang YH
J Cell Physiol; 2013 Feb; 228(2):476-84. PubMed ID: 22777765
[TBL] [Abstract][Full Text] [Related]
32. A novel peptide agonist of formyl-peptide receptor-like 1 (ALX) displays anti-inflammatory and cardioprotective effects.
Hecht I; Rong J; Sampaio AL; Hermesh C; Rutledge C; Shemesh R; Toporik A; Beiman M; Dassa L; Niv H; Cojocaru G; Zauberman A; Rotman G; Perretti M; Vinten-Johansen J; Cohen Y
J Pharmacol Exp Ther; 2009 Feb; 328(2):426-34. PubMed ID: 19023040
[TBL] [Abstract][Full Text] [Related]
33. Formyl peptide receptors and the regulation of ACTH secretion: targets for annexin A1, lipoxins, and bacterial peptides.
John CD; Sahni V; Mehet D; Morris JF; Christian HC; Perretti M; Flower RJ; Solito E; Buckingham JC
FASEB J; 2007 Apr; 21(4):1037-46. PubMed ID: 17218541
[TBL] [Abstract][Full Text] [Related]
34. Annexin 1 peptides protect against experimental myocardial ischemia-reperfusion: analysis of their mechanism of action.
La M; D'Amico M; Bandiera S; Di Filippo C; Oliani SM; Gavins FN; Flower RJ; Perretti M
FASEB J; 2001 Oct; 15(12):2247-56. PubMed ID: 11641252
[TBL] [Abstract][Full Text] [Related]
35. Enhanced neutrophil expression of annexin-1 in coronary artery disease.
Särndahl E; Bergström I; Nijm J; Forslund T; Perretti M; Jonasson L
Metabolism; 2010 Mar; 59(3):433-40. PubMed ID: 19850308
[TBL] [Abstract][Full Text] [Related]
36. Lipoxin A(4) metabolites/analogues from two commercial sources have no effects on TNF-alpha-mediated priming or activation through the neutrophil formyl peptide receptors.
Forsman H; Dahlgren C
Scand J Immunol; 2009 Oct; 70(4):396-402. PubMed ID: 19751275
[TBL] [Abstract][Full Text] [Related]
37. Anti-inflammatory role of the murine formyl-peptide receptor 2: ligand-specific effects on leukocyte responses and experimental inflammation.
Dufton N; Hannon R; Brancaleone V; Dalli J; Patel HB; Gray M; D'Acquisto F; Buckingham JC; Perretti M; Flower RJ
J Immunol; 2010 Mar; 184(5):2611-2619. PubMed ID: 20107188
[TBL] [Abstract][Full Text] [Related]
38. Annexin A1 and the Resolution of Inflammation: Modulation of Neutrophil Recruitment, Apoptosis, and Clearance.
Sugimoto MA; Vago JP; Teixeira MM; Sousa LP
J Immunol Res; 2016; 2016():8239258. PubMed ID: 26885535
[TBL] [Abstract][Full Text] [Related]
39. Honokiol suppresses formyl peptide-induced human neutrophil activation by blocking formyl peptide receptor 1.
Liu FC; Yu HP; Syu YT; Fang JY; Lin CF; Chang SH; Lee YT; Hwang TL
Sci Rep; 2017 Jul; 7(1):6718. PubMed ID: 28751674
[TBL] [Abstract][Full Text] [Related]
40. Up-regulation of Annexin-A1 and lipoxin A(4) in individuals with ulcerative colitis may promote mucosal homeostasis.
Vong L; Ferraz JG; Dufton N; Panaccione R; Beck PL; Sherman PM; Perretti M; Wallace JL
PLoS One; 2012; 7(6):e39244. PubMed ID: 22723974
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
